Centenial Surgical Suture Ltd
CSURGSUCentenial Surgical Suture Ltd
CSURGSUPrice Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
54.38 | 1.55 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
51.23 | 6.64 | 0.52% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Centenial Surgical Suture is a medical device company engaged in manufacturing surgical sutures and other medical devices. It's products include atraumatic needles and sutures (absorbable and non absorbable) and cardio blades
Peers
Compare with peersInventurus Knowledge Solutions Ltd
Poly Medicure Ltd
Tarsons Products Ltd
Borosil Scientific Ltd
PREVEST DENPRO LTD
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Revenue Forecast
Earnings Per Share Forecast
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 51.47 | 52.85 | 52.80 | 56.07 | 55.70 | 37.02 | 44.47 | 52.79 | 51.32 | 52.61 | ||||||||||
Raw Materials | 24.32 | 27.60 | 23.16 | 24.52 | 24.92 | 15.81 | 15.68 | 20.26 | 20.12 | 46.32 | ||||||||||
Power & Fuel Cost | 0.22 | 0.24 | 0.22 | 0.32 | 0.40 | 0.34 | 0.29 | 0.33 | 0.37 | |||||||||||
Employee Cost | 7.28 | 8.39 | 9.20 | 9.47 | 10.67 | 9.98 | 10.77 | 11.19 | 11.33 | |||||||||||
Selling & Administrative Expenses | 14.23 | 15.47 | 14.18 | 14.71 | 13.34 | 10.59 | 8.78 | 15.84 | 16.02 | |||||||||||
Operating & Other expenses | 0.72 | -3.74 | 1.51 | 1.64 | 0.36 | -4.90 | 4.42 | 0.64 | -1.80 | |||||||||||
EBITDA | 4.70 | 4.89 | 4.53 | 5.41 | 6.01 | 5.20 | 4.53 | 4.53 | 5.28 | 6.29 | ||||||||||
Depreciation/Amortization | 0.68 | 0.59 | 0.60 | 0.69 | 1.55 | 1.55 | 1.53 | 1.30 | 1.39 | 2.65 | ||||||||||
PBIT | 4.02 | 4.30 | 3.93 | 4.72 | 4.46 | 3.65 | 3.00 | 3.23 | 3.89 | 3.64 | ||||||||||
Interest & Other Items | 1.65 | 1.77 | 1.51 | 1.89 | 2.31 | 2.12 | 1.93 | 1.77 | 2.62 | 2.52 | ||||||||||
PBT | 2.37 | 2.53 | 2.42 | 2.83 | 2.15 | 1.53 | 1.07 | 1.46 | 1.27 | 1.12 | ||||||||||
Taxes & Other Items | 0.81 | 0.83 | 0.87 | 0.83 | 0.86 | 0.57 | 0.45 | 0.58 | 0.14 | 0.20 | ||||||||||
Net Income | 1.56 | 1.70 | 1.55 | 2.00 | 1.29 | 0.96 | 0.62 | 0.88 | 1.13 | 0.92 | ||||||||||
EPS | 2.47 | 2.36 | 2.15 | 2.78 | 1.79 | 1.33 | 0.86 | 1.22 | 1.57 | 1.28 | ||||||||||
DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CareHealth Care Equipment & Supplies
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Centenial Surgical Suture Ltd | 44.27 | 1.55 | — |
Inventurus Knowledge Solutions Ltd | 86.55 | 27.69 | 0.53% |
Poly Medicure Ltd | 99.33 | 17.45 | 0.11% |
Tarsons Products Ltd | 48.98 | 3.41 | 0.51% |
Price Comparison
Compare CSURGSU with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
CSURGSU has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Net profit of Centenial Surgical Suture declined 45.83% to Rs 0.13 crore in the quarter ended September 2024 as against Rs 0.24 crore during the previous quarter ended September 2023. Sales rose 8.93% to Rs 14.27 crore in the quarter ended September 2024 as against Rs 13.10 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales14.2713.10 9 OPM %12.128.78 - PBDT1.260.65 94 PBT0.170.33 -48 NP0.130.24 -46 Powered by Capital Market - Live
Centenial Surgical Suture will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live
Centenial Surgical Suture announced that the Annual General Meeting (AGM) of the company will be held on 27 September 2024.Powered by Capital Market - Live
Centenial Surgical Suture announced that the Annual General Meeting (AGM) of the company will be held on 27 September 2024.Powered by Capital Market - Live
Net profit of Centenial Surgical Suture rose 3.45% to Rs 0.30 crore in the quarter ended June 2024 as against Rs 0.29 crore during the previous quarter ended June 2023. Sales rose 0.59% to Rs 13.74 crore in the quarter ended June 2024 as against Rs 13.66 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales13.7413.66 1 OPM %12.528.49 - PBDT1.190.69 72 PBT0.400.39 3 NP0.300.29 3 Powered by Capital Market - Live
Centenial Surgical Suture will hold a meeting of the Board of Directors of the Company on 12 August 2024.Powered by Capital Market - Live
Centenial Surgical Suture standalone net profit declines 50.00% in the June 2021 quarter
Centenial Surgical Suture reports standalone net loss of Rs 0.04 crore in the March 2021 quarter
Centenial Surgical Suture standalone net profit declines 2.33% in the December 2020 quarter
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of -1.75%, vs industry avg of 16.6%
Decreasing Market Share
Over the last 5 years, market share decreased from 4.69% to 1%
Lower than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of -10.79%, vs industry avg of -5.3%